Who is sponsoring NCT04507672?

NCT04507672 is sponsored by Southeast University, China.

What drugs are being tested in NCT04507672?

Interventions in NCT04507672: Fluid resuscitation.

What condition does NCT04507672 study?

NCT04507672 studies Septic Shock Hyperdynamic.

Is NCT04507672 still recruiting?

NCT04507672 is currently status unknown. Last updated 11 August 2020.

Last reviewed 2020-08-11 · How we verify

NCT04507672

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acetated Ringer's Solution Versus Saline in Patients With Septic Shock

Status unknown NA Last updated 11 August 2020

What this trial tests

NA trial testing Fluid resuscitation in Septic Shock Hyperdynamic in 2,000 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
1 October 2023

1 December 2023

Quick facts

Lead sponsor	Southeast University, China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	2,000
Start date	1 September 2020
Primary completion	1 October 2023
Estimated completion	1 December 2023

Drugs / interventions tested

Fluid resuscitation — full drug profile →

Conditions studied

Septic Shock Hyperdynamic — all drugs for Septic Shock Hyperdynamic →

Sponsor

Southeast University, China

Who can join

Adults 18 to 90, any sex, with Septic Shock Hyperdynamic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fluid resuscitation

Trials testing the same drug.

NCT03188614 — Crystalloids for AKI in Shock Patients · NA · unknown

Other Southeast University, China trials

Trials by the same sponsor.

NCT07519512 — Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients · NA · recruiting
NCT06990477 — Effect of EIT-guided PEEP in ARDS Patients With Higher Recruitability · NA · recruiting
NCT07362537 — Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS · NA · recruiting
NCT07327268 — Cyclic On-off Switching of Pulmonary Blood Flow in Moderate to Severe ARDS · not yet recruiting
NCT07284888 — Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry- · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04507672 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Southeast University, China
Last refreshed: 11 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04507672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing